Suppression of fibroblast activity by an inhibitor of dipeptidyl peptidase IV. A possible therapeutic strategy for rheumatoid arthritis

被引：0
|
作者：
Williams, YN
Sugita, T
Nosaka, Y
Kubota, T
机构：
[1] Tokyo Med & Dent Univ, Grad Sch Allied Hlth Sci, Bunkyo Ku, Tokyo 1138519, Japan
[2] Discovery Res Lab, Osaka, Japan
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2003年 / 21卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：685 / 685
页数：1
相关论文
共 50 条
  • [31] In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4+ T lymphocytes
    Ellingsen, T.
    Hornung, N.
    Moller, B. K.
    Hjelm-Poulsen, J.
    Stengaard-Pedersen, K.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 66 (04) : 451 - 457
  • [32] Association of CD26/dipeptidyl peptidase IV mRNA level in peripheral blood mononuclear cells with disease activity and bone erosion in rheumatoid arthritis
    Farshid Yeganeh
    Seyed Mohammad Javad Mousavi
    Saeed Hosseinzadeh-Sarband
    Arman Ahmadzadeh
    Hooman Bahrami-Motlagh
    Mostafa Haji Molla Hoseini
    Mandana Sattari
    Mohammad Reza Sohrabi
    Ramin Pouriran
    Pooneh Dehghan
    Clinical Rheumatology, 2018, 37 : 3183 - 3190
  • [33] Association of CD26/dipeptidyl peptidase IV mRNA level in peripheral blood mononuclear cells with disease activity and bone erosion in rheumatoid arthritis
    Yeganeh, Farshid
    Mousavi, Seyed Mohammad Javad
    Hosseinzadeh-Sarband, Saeed
    Ahmadzadeh, Arman
    Bahrami-Motlagh, Hooman
    Hoseini, Mostafa Haji Molla
    Sattari, Mandana
    Sohrabi, Mohammad Reza
    Pouriran, Ramin
    Dehghan, Pooneh
    CLINICAL RHEUMATOLOGY, 2018, 37 (12) : 3183 - 3190
  • [34] Activity and expression of dipeptidyl peptidase IV on peripheral blood mononuclear cells in patients with early steroid and disease modifying antirheumatic drugs naive rheumatoid arthritis
    Grujic, Milica
    Matic, Ivana Z.
    Crnogorac, Marija Djordjic
    Velickovic, Ana Damjanovic
    Kolundzija, Branka
    Cordero, Oscar J.
    Juranic, Zorica
    Prodanovic, Slavica
    Zlatanovic, Maja
    Babic, Dragan
    Damjanov, Nemanja
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (01) : 73 - 81
  • [35] THE COMPARISON OF ACTIVITY DIPEPTIDYL PEPTIDASE IV (DPP-IV) INHIBITOR BETWEEN URENA LOBATA AND TITHONIA DIVERSIFOLIA LEAF EXTRACT
    Purnomo, Y.
    Soeatmadji, D. W.
    Sumitro, S. B.
    Widodo, M. A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S121 - S121
  • [36] Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity
    Baerts, Lesley
    Brouns, Raf
    Kehoe, Kaat
    Verkerk, Robert
    Engelborghs, Sebastiaan
    De Deyn, Peter Paul
    Hendriks, Dirk
    De Meester, Ingrid
    TRANSLATIONAL STROKE RESEARCH, 2017, 8 (02) : 157 - 164
  • [37] Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity
    Lesley Baerts
    Raf Brouns
    Kaat Kehoe
    Robert Verkerk
    Sebastiaan Engelborghs
    Peter Paul De Deyn
    Dirk Hendriks
    Ingrid De Meester
    Translational Stroke Research, 2017, 8 : 157 - 164
  • [38] An orally active, highly specific dipeptidyl peptidase IV inhibitor exhibits potent activity in a murine OGTT model
    Joshi, HV
    Narayanan, S
    Shah, DM
    Balasubramaniam, G
    Kumar, S
    Vakkalanka, SKVS
    DIABETES, 2004, 53 : A564 - A564
  • [39] Plasmin(ogen) carbohydrate chains mediate binding to dipeptidyl peptidase IV (CD 26) in rheumatoid arthritis human synovial fibroblasts
    Gonzalez-Gronow, M
    Weber, MR
    Shearin, TV
    Gawdi, G
    Pirie-Shepherd, SR
    Pizzo, SV
    FIBRINOLYSIS & PROTEOLYSIS, 1998, 12 (06): : 366 - 374
  • [40] Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients
    Buljevic, Suncica
    Detel, Dijana
    Pucar, Lara Baticic
    Mihelic, Radovan
    Madarevic, Tomislav
    Sestan, Branko
    Varljen, Jadranka
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (11) : 2867 - 2874
12345